glp 1 medication medicaid Indiana is expanding access to GLP-1s — the diabetes and weight loss medications — to members of the state's program. The expansion is part of a federal pilot to allow more GLP-1s prescriptions for weight loss

139,546 of those participants had type 2 diabetes and took a GLP-1

Monitoring Requirements While on Tirzepatide Baseline Labs Before starting tirzepatide, a clinician should review fasting glucose and HbA1c (to screen for undiagnosed type 2 diabetes), a comprehensive metabolic panel (to assess liver and kidney function), a lipid panel, and thyroid-stimulating hormone [9]

Increased GH levels can support fat loss, improve muscle tone, and enhance recovery

Also, hyperglycemia causes increased glucose and sodium reabsorption at the proximal tubule reducing the sodium delivery to the macula densa

Various conditions affecting the liver, gallbladder, or digestion can lead to changes in stool appearance